Spinal Muscular Atrophy Therapeutics: Where do we Stand?

Overview of attention for article published in Neurotherapeutics, January 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 1 X user
patent: 10 patents

wikipedia: 4 Wikipedia pages

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 141 Mendeley

Summary X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 10 patents that reference this research output.

Compositions and methods for treating motor neuron diseases

Grant US-11801284-B2

United States of America

USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES

Application EP-4218804-A3

European Patent Office

Methods for using anti-myostatin antibodies

Grant US-11439704-B2

United States of America

Compositions and methods for making and using anti-myostatin antibodies

Grant US-11155611-B2

United States of America

Methods for making and using anti-myostatin antibodies

Grant US-11135291-B2

United States of America

USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES

Application EP-3785728-A3

European Patent Office

Use of myostatin inhibitors and combination therapies

Grant US-10946036-B2

United States of America

Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin…

Grant US-10882904-B2

United States of America

Anti-pro/latent-Myostatin antibodies and uses thereof

Grant US-10751413-B2

United States of America

USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES

Application WO-2017218592-A1

World Intellectual Property Organisation (WIPO)